Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration

Sponsor
Nihon University
Study ID
NCT01824225
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial monthly intravitreal aflibercept for the Japanese age related macular degeneration.

Key Dates

Start date
Mar 31, 2013
Status verified
Oct 2015
Primary completion
Mar 31, 2014
Completion
Mar 31, 2015

Study Design

Enrollment
100 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: PRN injection of aflibercept
    Intravitreal aflibercept
  • Active Comparator: Two months injection of aflibercept
    Intravitreal afilibercept

Primary Outcome Measure

Visual acuity after treatment by PRN or 2 months intravitreal Aflibercept [ Time Frame: one year ]

Related Studies